Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Sterol Analysis by Quantitative Mass Spectrometry.

Jenner AM, Brown SHJ.

Methods Mol Biol. 2017;1583:221-239. doi: 10.1007/978-1-4939-6875-6_17.

PMID:
28205178
2.

Therapeutic Effects of Anthocyanins and Environmental Enrichment in R6/1 Huntington's Disease Mice.

Kreilaus F, Spiro AS, Hannan AJ, Garner B, Jenner AM.

J Huntingtons Dis. 2016 Oct 1;5(3):285-296.

PMID:
27567888
3.

Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.

Kreilaus F, Spiro AS, Hannan AJ, Garner B, Jenner AM.

J Huntingtons Dis. 2015;4(4):305-18. doi: 10.3233/JHD-150170.

PMID:
26639223
4.

Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue.

Kreilaus F, Spiro AS, McLean CA, Garner B, Jenner AM.

Neuropathol Appl Neurobiol. 2016 Oct;42(6):535-46. doi: 10.1111/nan.12286. Epub 2015 Oct 15.

PMID:
26373857
5.

Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice.

Li H, Ruberu K, Muñoz SS, Jenner AM, Spiro A, Zhao H, Rassart E, Sanchez D, Ganfornina MD, Karl T, Garner B.

Neurobiol Aging. 2015 May;36(5):1820-33. doi: 10.1016/j.neurobiolaging.2015.02.010. Epub 2015 Feb 19.

PMID:
25784209
6.

Fatty acid composition of the anterior cingulate cortex indicates a high susceptibility to lipid peroxidation in Parkinson's disease.

Abbott SK, Jenner AM, Spiro AS, Batterham M, Halliday GM, Garner B.

J Parkinsons Dis. 2015;5(1):175-85. doi: 10.3233/JPD-140479.

PMID:
25613350
7.

Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.

Cheng D, Spiro AS, Jenner AM, Garner B, Karl T.

J Alzheimers Dis. 2014;42(4):1383-96. doi: 10.3233/JAD-140921.

PMID:
25024347
8.

Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels.

Bhatia S, Jenner AM, Li H, Ruberu K, Spiro AS, Shepherd CE, Kril JJ, Kain N, Don A, Garner B.

J Alzheimers Dis. 2013;35(3):475-86. doi: 10.3233/JAD-122278.

PMID:
23455990
9.

Lipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosus.

Jovanović V, Abdul Aziz N, Lim YT, Ng Ai Poh A, Jin Hui Chan S, Ho Xin Pei E, Lew FC, Shui G, Jenner AM, Bowen L, McKinney EF, Lyons PA, Kemeny MD, Smith KG, Wenk MR, Macary PA.

PLoS One. 2013;8(2):e55639. doi: 10.1371/journal.pone.0055639. Epub 2013 Feb 7.

10.

An improved high-throughput lipid extraction method for the analysis of human brain lipids.

Abbott SK, Jenner AM, Mitchell TW, Brown SH, Halliday GM, Garner B.

Lipids. 2013 Mar;48(3):307-18. doi: 10.1007/s11745-013-3760-z. Epub 2013 Jan 26.

PMID:
23355308
11.

Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease.

Lim L, Jackson-Lewis V, Wong LC, Shui GH, Goh AX, Kesavapany S, Jenner AM, Fivaz M, Przedborski S, Wenk MR.

Cell Death Differ. 2012 Mar;19(3):416-27. doi: 10.1038/cdd.2011.105. Epub 2011 Aug 5.

12.

Increased expression of acyl-coenzyme A: cholesterol acyltransferase-1 and elevated cholesteryl esters in the hippocampus after excitotoxic injury.

Kim JH, Ee SM, Jittiwat J, Ong ES, Farooqui AA, Jenner AM, Ong WY.

Neuroscience. 2011 Jun 30;185:125-34. doi: 10.1016/j.neuroscience.2011.04.018. Epub 2011 Apr 14.

PMID:
21514367
13.

Lipid pathway alterations in Parkinson's disease primary visual cortex.

Cheng D, Jenner AM, Shui G, Cheong WF, Mitchell TW, Nealon JR, Kim WS, McCann H, Wenk MR, Halliday GM, Garner B.

PLoS One. 2011 Feb 28;6(2):e17299. doi: 10.1371/journal.pone.0017299.

14.

Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice.

Wong YT, Gruber J, Jenner AM, Tay FE, Ruan R.

Age (Dordr). 2011 Sep;33(3):229-46. doi: 10.1007/s11357-010-9174-4. Epub 2010 Aug 21.

15.

Up-regulation of endoplasmic reticulum stress-related genes during the early phase of treatment of cultured cortical neurons by the proteasomal inhibitor lactacystin.

Choy MS, Chen MJ, Manikandan J, Peng ZF, Jenner AM, Melendez AJ, Cheung NS.

J Cell Physiol. 2011 Feb;226(2):494-510. doi: 10.1002/jcp.22359.

PMID:
20683911
16.

The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice.

Jenner AM, Lim WL, Ng MP, Wenk MR, Shui G, Sharman MJ, Gandy SE, Martins RN.

Neuroscience. 2010 Aug 11;169(1):109-15. doi: 10.1016/j.neuroscience.2010.04.026. Epub 2010 Apr 21.

17.

Changes in brain cholesterol metabolome after excitotoxicity.

Ong WY, Kim JH, He X, Chen P, Farooqui AA, Jenner AM.

Mol Neurobiol. 2010 Jun;41(2-3):299-313. doi: 10.1007/s12035-010-8099-3. Epub 2010 Feb 6. Review.

PMID:
20140539
18.

Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress.

European Standards Committee on Urinary (DNA) Lesion Analysis, Evans MD, Olinski R, Loft S, Cooke MS.

FASEB J. 2010 Apr;24(4):1249-60. doi: 10.1096/fj.09-147124. Epub 2009 Dec 4.

19.

Changes in cholesterol biosynthetic and transport pathways after excitotoxicity.

Kim JH, Jittiwat J, Ong WY, Farooqui AA, Jenner AM.

J Neurochem. 2010 Jan;112(1):34-41. doi: 10.1111/j.1471-4159.2009.06449.x. Epub 2009 Oct 24.

20.

A metabolite profiling approach to identify biomarkers of flavonoid intake in humans.

Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD.

J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.

PMID:
19812218

Supplemental Content

Loading ...
Support Center